MVision AI

Seed · AI & Machine Learning · Helsinki, Finland · Founded 2017 · 30–50 employees

MVision AI is a Helsinki-based healthtech company that has developed AI-powered automatic segmentation tools for radiotherapy treatment planning, revolutionizing cancer care by reducing treatment waiting times from weeks to potentially same-day treatment. Their cloud-based platform has already been used to treat over 170,000 cancer patients across 24 countries, with their Contour+ solution reducing contouring time by up to 95% while maintaining high quality standards. The company secured €5.4 million in post-seed funding in March 2023, led by J12 Ventures and Voima Ventures, to accelerate global expansion and product development. Additionally, they received €2.8 million in R&D funding from Business Finland in 2025 to advance their radiotherapy innovation.

No open roles listed right now.